Michael Diefenbeck New CMO of BONESUPPORT
Elizabeth Hofheinz, M.P.H., M.Ed. • Thu, April 20th, 2017
Michael Diefenbeck M.D., Ph.D., founder of Scientific Consulting in Orthopaedic Surgery, has been appointed Chief Medical Officer (CMO) at BONESUPPORT AB. The company, focused on injectable bioceramic bone scaffolds, is based in Lund, Sweden.
According to the April 11, 2017 news release, “Dr. Diefenbeck…has worked for BONESUPPORT on a range of clinical projects related to CERAMENT as an independent clinical advisor. He is currently honorary consultant at Nuffield Orthopaedic Centre, Oxford University Hospitals. Dr. Diefenbeck studied medicine at Munich and was trained as an orthopaedic surgeon, specializing in trauma care and bone infections. He has 14 years’ clinical experience at different German hospitals (BG Unfallklinik Murnau, BG Kliniken Bergmannstrost Halle/Saale, University Hospital Jena and Schön Klinik Hamburg Eilbek). At University Hospital Jena he finished his Ph.D. in 2011 and has since been involved in surgical education and training programs for students. He is author of 24 Pub-med listed research articles.”
Dr Diefenbeck said: “I am excited to be joining BONESUPPORT at a particularly exciting time for the company. I look forward to working with the BONESUPPORT team.”
Richard Davies, CEO of BONESUPPORT, said: “We are pleased to welcome Michael to the BONESUPPORT team. I have no doubt that his extensive medical experience in the orthopaedics field and his knowledge of our CERAMENT platform that he will be a real asset to BONESUPPORT as we look to grow our business and deliver value to all of our stakeholders.”
Dr. Diefenbeck told OTW, “Now that I am in the post, I look forward to helping shape the future development of BONESUPPORT, as the company continues to develop and reinforce the clinical benefits its CERAMENT based products delivery.”